Metoprolol Succinate
NDC Package 0904-6170-05

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Metoprolol Succinate is a medication a beta-blocker used to treat chest pain (angina), heart failure, and high blood pressure. Marketed by Major Pharmaceuticals, this product is identified by NDC 0904-6170 and is authorized under FDA application ANDA090615.

Identification & Billing

NDC Package Code
0904-6170-05
Package Description
10 BOX, UNIT-DOSE in 1 CARTON / 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOX, UNIT-DOSE (0904-6170-61)
Product Code
0904-6170
11-Digit Billing Format
00904617005

Clinical Specifications

Proprietary Name
Metoprolol Succinate
Dosage Form
-
Usage Information
This medication is a beta-blocker used to treat chest pain (angina), heart failure, and high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This drug works by blocking the action of certain natural chemicals in your body (such as epinephrine) that affect the heart and blood vessels. This lowers heart rate, blood pressure, and strain on the heart.

Regulatory & Marketing

Labeler Name
Major Pharmaceuticals
FDA Application #
ANDA090615
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
10-05-2010
End Marketing Date
07-17-2018
Listing Expiration
07-17-2018
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0904-6170-05 identifies a specific commercial package of 10 box, unit-dose in 1 carton / 100 tablet, film coated, extended release in 1 box, unit-dose (0904-6170-61) of Metoprolol Succinate, labeled by Major Pharmaceuticals. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Major Pharmaceuticals on October 05, 2010. The current certification is valid through July 17, 2018.

What are the primary indications for this medication?

This medication is a beta-blocker used to treat chest pain (angina), heart failure, and high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This drug works by blocking the action of certain natural chemicals in your body (such as epinephrine) that affect the heart and blood vessels. This lowers heart rate, blood pressure, and strain on the heart.

How is this Major Pharmaceuticals product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00904617005. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0904-6170-05
11-Digit CMS (5-4-2)
00904-6170-05

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.